EUVIMEDEUVIMED entdecken
Crossref

Skin innervation across amyotrophic lateral sclerosis clinical stages: new prognostic biomarkers

Maria Nolano iD, Vincenzo Provitera iD, Giuseppe Caporaso iD, Ines Fasolino, Ilaria Borreca, Annamaria Stancanelli, Valentina V Iuzzolino, Gianmaria Senerchia, Floriana Vitale, Stefano Tozza iD, Lucia Ruggiero, Rosa Iodice und 4 weitere

Brain · 2024

DOI: 10.1093/brain/awad426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Maria Nolano und 15 weiteren Autor:innen. Beteiligte Einrichtung: Istituti Clinici Scientifici Maugeri IRCCS, Skin Biopsy Lab, Neurological Rehabilitation Unit of Telese Terme Institute, Telese Terme, Benevento 8203…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Skin. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Istituti Clinici Scientifici Maugeri IRCCS, Italian Ministry of Health, Ministry of University and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over recent decades, peripheral sensory abnormalities, including the evidence of cutaneous denervation, have been reported among the non-motor manifestations in amyotrophic lateral sclerosis (ALS). However, a correlation between cutaneous innervation and clinical features has not been found. The aims of this study were to assess sensory involvement by applying a morpho-functional approach to a large population of ALS patients stratified according to King’s stages and correlate these findings with the severity and prognosis of the disease. We recruited 149 ALS patients and 41 healthy controls. Patients undertook clinical questionnaires for small fibre neuropathy symptoms (Small Fiber Neuropathy Symptoms Inventory Questionnaire) and underwent nerve conductions studies (NCS) and 3-mm punch skin biopsies from leg, thigh and fingertip. We assessed intraepidermal nerve fibre (IENF) and Meissner corpuscle (MC) density by applying an indirect immunofluorescence technique. Moreover, a subset of 65 ALS patients underwent a longitudinal study with repeat biopsies from the thigh at 6- and 12-month follow-ups. Serum NfL levels were measured in 40 patients. Sensory symptoms and sensory NCS abnormalities were present in 32.2% and 24% of patients, respectively, and increased across clinical stages. Analogously, we observed a progressive reduction in amplitude of the sensory and motor ulnar nerve potential from stage 1 to stage 4. Skin biopsy showed a significant loss of IENFs and MCs in ALS compared with healthy controls (all P < 0.001). Across the clinical stages, we found a progressive reduction in MCs (P = 0.004) and an increase in IENFs (all P < 0.027). The increase in IENFs was confirmed by the longitudinal study. Interestingly, the MC density inversely correlated with NfL level (r = −0.424, P = 0.012), and survival analysis revealed that low MC density, higher NfL levels and increasing IENF density over time were associated with a poorer prognosis (all P < 0.024). To summarize, in patients with ALS, peripheral sensory involvement worsens in parallel with motor disability. Furthermore, the correlation between skin innervation and disease activity may suggest the use of skin innervation as a putative prognostic biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisSkinHumansMaleFemaleMiddle AgedAgedPrognosisBiomarkersNeural ConductionAdultDisease ProgressionNeurofilament ProteinsLongitudinal Studies

Stichwörter der Autor:innen

King’s staging systemnon-motor symptomspainprognosissensory neuropathysmall fibre pathology

Substanzen

BiomarkersNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Istituti Clinici Scientifici Maugeri IRCCS, Skin Biopsy Lab, Neurological Rehabilitation Unit of Telese Terme Institute, Telese Terme, Benevento 82037, Italy.
  • Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples 80131, Italy.
  • Institute of Polymers, Composites and Biomaterials-National Research Council (IPCB-CNR), Naples 80125, Italy.
  • Neurology Unit, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Policlinico GB Rossi, Verona 37134, Italy.

ORCID-Profile: Maria Nolano, Vincenzo Provitera, Giuseppe Caporaso, Stefano Tozza, Fiore Manganelli, Raffaele Dubbioso

Förderung

  • Istituti Clinici Scientifici Maugeri IRCCS
  • Italian Ministry of Health
  • Ministry of University and Research

Zitieren

APA

Nolano, M., Provitera, V., Caporaso, G., Fasolino, I., Borreca, I., Stancanelli, A., Iuzzolino, V. V., Senerchia, G., Vitale, F., Tozza, S., Ruggiero, L., Iodice, R., Ferrari, S., Santoro, L., Manganelli, F., & Dubbioso, R. (2024). Skin innervation across amyotrophic lateral sclerosis clinical stages: new prognostic biomarkers. Brain. https://doi.org/10.1093/brain/awad426

Vancouver

Nolano M, Provitera V, Caporaso G, Fasolino I, Borreca I, Stancanelli A, et al. Skin innervation across amyotrophic lateral sclerosis clinical stages: new prognostic biomarkers. Brain. 2024. doi:10.1093/brain/awad426

BibTeX
@article{Nolano2024,
  author = {Nolano, Maria and Provitera, Vincenzo and Caporaso, Giuseppe and Fasolino, Ines and Borreca, Ilaria and Stancanelli, Annamaria and Iuzzolino, Valentina V and Senerchia, Gianmaria and Vitale, Floriana and Tozza, Stefano and Ruggiero, Lucia and Iodice, Rosa and Ferrari, Sergio and Santoro, Lucio and Manganelli, Fiore and Dubbioso, Raffaele},
  title = {Skin innervation across amyotrophic lateral sclerosis clinical stages: new prognostic biomarkers},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awad426}
}
Kostenlos starten →